"BCG Vaccine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An active immunizing agent and a viable avirulent attenuated strain of Mycobacterium tuberculosis, var. bovis, which confers immunity to mycobacterial infections. It is used also in immunotherapy of neoplasms due to its stimulation of antibodies and non-specific immunity.
Concept/Terms
BCG Vaccine- BCG Vaccine
- Vaccine, BCG
- Bacillus Calmette Guerin Vaccine
- Calmette Guerin Bacillus Vaccine
- Calmette's Vaccine
- Calmette Vaccine
- Calmettes Vaccine
- Vaccine, Calmette's
Below are MeSH descriptors whose meaning is more general than "BCG Vaccine".
Below are MeSH descriptors whose meaning is more specific than "BCG Vaccine".
This graph shows the total number of publications written about "BCG Vaccine" by people in Harvard Catalyst Profiles by year, and whether "BCG Vaccine" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 3 | 3 | 6 |
| 1994 | 1 | 0 | 1 |
| 1995 | 8 | 5 | 13 |
| 1996 | 4 | 2 | 6 |
| 1997 | 3 | 0 | 3 |
| 1998 | 1 | 0 | 1 |
| 1999 | 1 | 2 | 3 |
| 2000 | 4 | 2 | 6 |
| 2001 | 2 | 2 | 4 |
| 2002 | 1 | 0 | 1 |
| 2003 | 2 | 1 | 3 |
| 2004 | 1 | 0 | 1 |
| 2005 | 5 | 2 | 7 |
| 2006 | 3 | 1 | 4 |
| 2007 | 7 | 1 | 8 |
| 2008 | 4 | 2 | 6 |
| 2009 | 4 | 0 | 4 |
| 2010 | 0 | 3 | 3 |
| 2011 | 1 | 1 | 2 |
| 2012 | 3 | 0 | 3 |
| 2013 | 6 | 2 | 8 |
| 2014 | 4 | 2 | 6 |
| 2015 | 2 | 4 | 6 |
| 2016 | 1 | 2 | 3 |
| 2017 | 8 | 4 | 12 |
| 2018 | 9 | 2 | 11 |
| 2019 | 3 | 3 | 6 |
| 2020 | 6 | 3 | 9 |
| 2021 | 12 | 4 | 16 |
| 2022 | 3 | 9 | 12 |
| 2023 | 1 | 6 | 7 |
Below are the most recent publications written about "BCG Vaccine" by people in Profiles.
-
Timing of maternal isoniazid preventive therapy on tuberculosis infection among infants exposed to HIV in low-income and middle-income settings: a secondary analysis of the TB APPRISE trial. Lancet Child Adolesc Health. 2023 10; 7(10):708-717.
-
New tuberculosis vaccines in India: modelling the potential health and economic impacts of adolescent/adult vaccination with M72/AS01E and BCG-revaccination. BMC Med. 2023 08 04; 21(1):288.
-
Airway T cells are a correlate of i.v. Bacille Calmette-Guerin-mediated protection against tuberculosis in rhesus macaques. Cell Host Microbe. 2023 Jun 14; 31(6):962-977.e8.
-
Association of BCG Vaccine Treatment With Death and Dementia in Patients With Non-Muscle-Invasive Bladder Cancer. JAMA Netw Open. 2023 05 01; 6(5):e2314336.
-
The MotoNet: A 3 Tesla MRI-Conditional EEG Net with Embedded Motion Sensors. Sensors (Basel). 2023 Mar 28; 23(7).
-
A MAPS Vaccine Induces Multipronged Systemic and Tissue-Resident Cellular Responses and Protects Mice against Mycobacterium tuberculosis. mBio. 2023 02 28; 14(1):e0361122.
-
A Phase 1 Trial of Durvalumab in Combination with Bacillus Calmette-Guerin (BCG) or External Beam Radiation Therapy in Patients with BCG-unresponsive Non-muscle-Invasive Bladder Cancer: The Hoosier Cancer Research Network GU16-243 ADAPT-BLADDER Study. Eur Urol. 2023 06; 83(6):486-494.
-
Cost-Effectiveness of Nadofaragene Firadenovec and Pembrolizumab in Bacillus Calmette-Guérin Immunotherapy Unresponsive Non-Muscle Invasive Bladder Cancer. Value Health. 2023 06; 26(6):823-832.
-
Optimizing DNA Extraction from Pediatric Stool for Diagnosis of Tuberculosis and Use in Next-Generation Sequencing Applications. Microbiol Spectr. 2023 02 14; 11(1):e0226922.
-
Disparities in the prevalence and management of high-risk non-muscle invasive bladder cancer. Urol Oncol. 2023 05; 41(5):255.e15-255.e21.